|
Bacteria-specific CXCL13-producing follicular helper T cells are putative prognostic markers to neoadjuvant PD-1 blockade in muscle-invasive urothelial carcinoma. |
|
|
Employment - Debiopharm Group (I) |
|
Carolina Alves Costa Silva |
No Relationships to Disclose |
|
Leonardo Lordello De Melo |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bayer; Bouchara Recordati; Ipsen |
Research Funding - Astellas Amgen BioPharama |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; Bouchara Recordati; Bristol-Myers Squibb/Pfizer; Ipsen; Janssen-Cilag; Roche |
Consulting or Advisory Role - Janssen-Cilag; MSD Oncology (Inst); Pfizer; Roche |
Expert Testimony - Astellas Pharma; Bouchara Recordati; Janssen |
Travel, Accommodations, Expenses - Astellas Pharma; Ferring; Ipsen; Janssen-Cilag; Pfizer |
|
|
Honoraria - Astellas Amgen BioPharama; AstraZeneca; Bayer; Janssen; Roche; Sanofi |
|
|
Consulting or Advisory Role - Arquer Diagnostics; GlaxoSmithKline; Intuitive Surgical; Ipsen; Janssen-Cilag; Lilly; MSD; Roche; Sanofi; Takeda |
Travel, Accommodations, Expenses - Astellas Pharma; Coloplast |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Patents, Royalties, Other Intellectual Property - EverImmune |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Patents, Royalties, Other Intellectual Property - EverImmune |
|
|
Honoraria - Pfizer; Sanofi |
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Immunomedics; Janssen; Janssen (Inst); MSD Oncology; MSD Oncology (Inst); Roche; Seagen; Taiho Pharmaceutical |
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); CureVac (Inst); Exelixis (Inst); Incyte (Inst); Janssen Oncology (Inst); Medivation (Inst); MSD Oncology (Inst); Nektar (Inst); Oncogenex (Inst); Pfizer (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Janssen Oncology; MSD Oncology; Roche; Seagen |